Treatment of Alzheimer's Disease With CX516 (Ampalex)

NCT00001662 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

NIH

Sponsor class

Conditions

Alzheimer's Disease
Dementia

Interventions

DRUG: CX516 (Ampalex)

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)